Editorial
Published on 30 May 2022
Editorial: Angiogenesis and Nutraceuticals
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.943158
- 1,974 views
- 2 citations
Type at least 3 characters
1,204 articles
Articles
Editorial
Published on 26 May 2022
Editorial: Myocardial Remodeling: Mechanisms and Translational Implications
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.930387
- 1,762 views
Original Research
Published on 25 May 2022
Circadian Dependence of the Acute Immune Response to Myocardial Infarction
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.869512
- 3,626 views
- 7 citations
Original Research
Published on 25 May 2022
Epigenetic Reader Bromodomain Containing Protein 2 Facilitates Pathological Cardiac Hypertrophy via Regulating the Expression of Citrate Cycle Genes
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.887991
- 3,137 views
- 3 citations
Original Research
Published on 24 May 2022
Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.816059
- 2,268 views
- 6 citations
Original Research
Published on 24 May 2022
Resveratrol Attenuate Myocardial Injury by Inhibiting Ferroptosis Via Inducing KAT5/GPX4 in Myocardial Infarction
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.906073
- 5,195 views
- 42 citations
Original Research
Published on 23 May 2022
Characteristics and Predictors of Venous Thromboembolism Among Lymphoma Patients Undergoing Chemotherapy: A Cohort Study in China
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.901887
- 1,849 views
- 4 citations
Original Research
Published on 23 May 2022
Neohesperidin Protects Angiotensin II-Induced Hypertension and Vascular Remodeling
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.890202
- 3,194 views
- 12 citations
Original Research
Published on 23 May 2022
Mechanism and Protective Effect of Smilax glabra Roxb on the Treatment of Heart Failure via Network Pharmacology Analysis and Vitro Verification
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.868680
- 3,672 views
- 2 citations
Editorial
Published on 23 May 2022
Editorial: Interplays and Functions of Gaseous Mediators: From Underlying Mechanisms to Therapeutic Approaches in Cardiovascular Diseases
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.925561
- 1,464 views
Original Research
Published on 20 May 2022
A Systematic Review and Meta-Analysis of Phytoestrogen Protects Against Myocardial Ischemia/Reperfusion Injury: Pre-Clinical Evidence From Small Animal Studies
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.847748
- 4,802 views
- 4 citations
Review
Published on 20 May 2022
The Role of CXC Chemokines in Cardiovascular Diseases
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.765768
- 6,672 views
- 31 citations
Editorial
Published on 19 May 2022
Editorial: Hyperglycemia and Coronary Artery Diseases: Physio-Pathological Findings and Therapeutic Implications
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.901815
- 1,176 views
- 5 citations
Brief Research Report
Published on 17 May 2022
Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.868365
- 4,164 views
- 5 citations
Original Research
Published on 17 May 2022
Red Blood Cell Membrane-Camouflaged PLGA Nanoparticles Loaded With Basic Fibroblast Growth Factor for Attenuating Sepsis-Induced Cardiac Injury
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.881320
- 3,338 views
- 14 citations
Original Research
Published on 17 May 2022
Plasma Rivaroxaban Level in Patients With Early Stages of Chronic Kidney Disease—Relationships With Renal Function and Clinical Events
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.888660
- 3,544 views
- 9 citations